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別紙様式3 (課程博士 •論文博士共用)
論 文 内 容 要 旨
X整理番号 8 14 氏 名 PHAM MI・ NGOC
学位論文題目
In vivo antitumor function of tumor antigen-specific CTLs generated 
in the presence of 0X40 co-stimulation in vitro 
( in で 0X40補助刺激存在下に誘導された腫瘍抗原特異的
CTLの/ぶn w での抗腫瘍機能について）
Purpose:
Adoptive cell transfer (ACT) is one of anticancer immunotherapies. In ACT, tumor-reactive 
T cells are generated to a large population before transfer back to patients with cancer. 0X40, 
a member ofTNRF (tumor necrosis factor receptor) family, are receptors expressed on activated 
CD4+ and CD8+ T cells. Antitumor effects of 0X 40 were well established when additional 
0X 40 signals were induced in recipients before ACT. Here, we aim to investigate the affects 
of 0X40 co-stimulation on the T cells generated in vitro as well as the in vivo antitumor effects
of these 0X 40 co-stimulated T cells in afterward ACT.
Methods:
• Tumor antigen: We used wild type FVB mice in a model of mammary tumor. The 
tumor expressing neu antigen was established by NT cell line. Neu-expressing vaccine cell line 
3T3 neu/GM was used to amplify neu-reactive T cells in donor mice. In vitro, neu-specific 
CD8+T cells were activated and re-stimulated by RNEU peptide, an immunodominant peptide 
o f neu, which was presented by an MHC I restricted APC cell: the T2Dq cell line.
・ In vitro CTL generation: Donor FVB mice had been inoculated with NT cell line and 
vaccinated with 3T3 neu/GM cell line before their splenic T cells were purified and cultivated 
for 7 days. The cultivation included T cells and RNEU-pulsed T2Dq cells in the presence or 
absence of anti 0X 40 mAb. After 7 days, CD8+ T cells were separated from cultivation by 
magnet field and were used in ACT.
・ Adoptive cell transfer therapy: Recipient FVB mice were challenged with tumor NT 
cell line 3 days before receiving the CD8+ T cells that had been co-stimulated by anti 0X40 
mAb or not. Control group was injected with PBS.
・ Evaluation methods: Tumor sizes in recipients were observed every 3 days. 
Frequencies of neu-specific CTLs were assessed by ICS for the CD8+ T cells secreting IFN-y+ 
as response to RNEU re-stimulation.
(備考） 1 . 論文内容要旨は、研究の目的•方 法 •結 果 •考 察 •結論の順に記載し、 2 千字 
程度でタイプ等を用いて印字すること。
2 . ※印の欄には記入しないこと。
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(続紙）
Expressions of CD27, CD62L, CCR7, and Bcl2 were identified by ICS for corresponding 
marker gated on neu-specific CTLs population. Proliferation of neu-specific CTLs were 
adjusted by staining donor T cells before in vitro generation, otherwise staining the CD8+ T 
cells before transfer with CFSE. The CFSE dilution gated on IFN-y+ CD8+ T cells revealed 
proliferation profile o f the cells.
Results:
The antigen-specific CTLs generated in vitro under 0X40 co-stimulation proliferated less and 
therefore, expand to a smaller number than those generated without 0X40 signal. However, the 
0X40 co-stimulated CTLs population expressed more CD27, CD62L, CCR7 markers, as well 
as Bcl2 protein than the CTLs that had not been co-stimulated in vitro.
After transfer to tumor-bearing recipients, CTLs derived from cultivation with anti 0X40 mAb 
proliferated remarkably in vivo. They manifested potent antitumor function and finally 
eradicated the established tumors. Whereas, the CTLs not receiving 0X40 signals in vitro, 
though being transferred with larger number, did not proliferated in vivo and just caused a 
transient delay in tumor growth. On day 45 after ACT, the transferred T cells that had been 
generated with 0X40 signal were still detectable in recipient mice.
Discussion:
In vitro 0X 40 signal drove the generated CTLs towards earlier differentiation as they 
expressed more markers of early states like CD27, CD62L, CCR7. The younger CTLs possess 
higher proliferation potential and more effective antitumor function. OX40-derived CTLs also 
had more anti-apoptotic Bcl2 protein, which can explain for their long persistence in vivo.
Our findings established for the first time the benefits of 0X 40 signal in vitro towards the in 
vivo antitumor effects of CTLs generated for ACT. By appropriate modulation, a small number 
of CTLs could function effectively and finally eliminated tumor. This result consolidated the 
fact that quality of transferred cells is important contribution to successful ACT therapy.
Additional 0X40 co-stimulation was induced in patients with progressive cancer as a signal 
modulation therapy. The trial showed ability in clinical application of 0X40, but also quoted 
problem of systemic toxicity caused by the modulation molecule. By applying 0X40 signal 
directly to T cells during in vitro expansion, the possibility of systemic toxics can be excluded 
while favorable affects of 0X 40 co-stimulation on tumor-reactive CTLs still remain.
Conclusions:
Generating CTLs with 0X 40 co-stimulation in vitro optimized the in vivo antitumor effects 
of these cells as ACT therapy. This approach prevents systemic toxicity in patients and 
minimizes the amount of expensive modulatory molecules.
別紙様式8 (課程博士 •論文博士共用)
学位論文審査の結果の要旨
整理番号 8  1 4 氏 名 PHAM MI・  NGOC
論文審査委員
(学位論文審査の結果の要旨）※明朝体 1 1 ポイント、 6  () 0 字以内で作成のこと
本論文では、0 X 4 0補助刺激下に///け/卯で作製した抗原特異的C.TLを用いた養子免疫 
療法のマウス乳癌 （H E R 2 /n e u陽性）モデルにおける抗腫瘍効果を明らかにすることを目的 
として研究を行った。そのため、n e u 発現 N T腫瘍細胞を移植したドナーF V Bマウスを n eu  
発現細胞である 3T3 n e u /G M で免疫し、摘出した脾臓から採取したn e u 反応性 T 細胞を RNEU 
ペプチドでパルスしたT2D[I抗原提示細胞と共培養してn e u 特異的 CD8_ T 細 胞 （C T L )を作 
製した。N T 細胞移植 F V Bマウスへ養子免疫するC T Lは抗 0 X 4 0抗体による補助刺激の有無 
で 2 通り用意し、P B S群を加えた 3 群による投与試験を行い、以下の点を明らかにした。
1 )  0 X 4 0補助刺激下ではブけ7 卯 で作製される抗原特異的C T Lの数は少ない傾向にある 
が、これらのC T Lは CD27、CD62L、CCR7、B c l 2 を高レベルに発現している。
2 )  0 X 4 0補助刺激下で作製された抗原特異的C T Lは//? で顕著に増殖し、抗腫瘍効果
を示す。
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